These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8817557)

  • 1. Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor.
    Golombek DA; Biello SM; Rendon RA; Harrington ME
    Neuroreport; 1996 May; 7(7):1315-9. PubMed ID: 8817557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro.
    Biello SM; Golombek DA; Harrington ME
    Neuroscience; 1997 Apr; 77(4):1049-57. PubMed ID: 9130786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor.
    Huhman KL; Gillespie CF; Marvel CL; Albers HE
    Neuroreport; 1996 May; 7(7):1249-52. PubMed ID: 8817542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y phase advances the in vitro hamster circadian clock during the subjective day with no effect on phase during the subjective night.
    Harrington ME; Schak KM
    Can J Physiol Pharmacol; 2000 Feb; 78(2):87-92. PubMed ID: 10737670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
    Gribkoff VK; Pieschl RL; Wisialowski TA; van den Pol AN; Yocca FD
    J Neurosci; 1998 Apr; 18(8):3014-22. PubMed ID: 9526018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPY opposes PACAP phase shifts via receptors different from those involved in NPY phase shifts.
    Harrington ME; Hoque S
    Neuroreport; 1997 Aug; 8(12):2677-80. PubMed ID: 9295099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro.
    Prosser RA
    Brain Res; 1998 Oct; 808(1):31-41. PubMed ID: 9795117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian phase shifts to neuropeptide Y In vitro: cellular communication and signal transduction.
    Biello SM; Golombek DA; Schak KM; Harrington ME
    J Neurosci; 1997 Nov; 17(21):8468-75. PubMed ID: 9334419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus.
    Fukuhara C; Brewer JM; Dirden JC; Bittman EL; Tosini G; Harrington ME
    Neurosci Lett; 2001 Nov; 314(3):119-22. PubMed ID: 11704298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist.
    Lall GS; Biello SM
    Neuroscience; 2003; 119(2):611-8. PubMed ID: 12770573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
    Yannielli PC; Harrington ME
    J Neurosci; 2001 Jul; 21(14):5367-73. PubMed ID: 11438613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the NPY Y5 receptor potentiates circadian responses to light: complementary in vivo and in vitro studies.
    Yannielli PC; Brewer JM; Harrington ME
    Eur J Neurosci; 2004 Feb; 19(4):891-7. PubMed ID: 15009136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses to neuropeptide Y in adult hamster suprachiasmatic nucleus neurones in vitro.
    Cutler DJ; Piggins HD; Selbie LA; Mason R
    Eur J Pharmacol; 1998 Mar; 345(2):155-62. PubMed ID: 9600631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness.
    Huhman KL; Albers HE
    Peptides; 1994; 15(8):1475-8. PubMed ID: 7700850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro.
    Soscia SJ; Harrington ME
    Brain Res; 2004 Oct; 1023(1):148-53. PubMed ID: 15364030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of membrane conductances and protein synthesis in subjective day phase advances of the hamster circadian clock by neuropeptide Y.
    Hall AC; Earle-Cruikshanks G; Harrington ME
    Eur J Neurosci; 1999 Oct; 11(10):3424-32. PubMed ID: 10564350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y: role in light-dark cycle entrainment of hamster circadian rhythms.
    Albers HE; Ferris CF
    Neurosci Lett; 1984 Sep; 50(1-3):163-8. PubMed ID: 6548555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term constant light potentiation of large-magnitude circadian phase shifts induced by 8-OH-DPAT: effects on serotonin receptors and gene expression in the hamster suprachiasmatic nucleus.
    Duncan MJ; Franklin KM; Davis VA; Grossman GH; Knoch ME; Glass JD
    Eur J Neurosci; 2005 Nov; 22(9):2306-14. PubMed ID: 16262668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effects of NPY in the suprachiasmatic nucleus.
    Gamble KL; Paul KN; Karom MC; Tosini G; Albers HE
    Eur J Neurosci; 2006 May; 23(9):2488-94. PubMed ID: 16706855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.
    Soscia SJ; Harrington ME
    Neurosci Lett; 2005 Jan; 373(3):175-8. PubMed ID: 15619538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.